3+ hour, 6+ min ago   (92+ words) This June, ten of the life sciences industry’s most respected board members came to New York for Accenture’s second annual Life Sciences Board Forum for something this industr... Ten life sciences board directors on AI's three hardest questions: developing the…...

2+ day, 3+ hour ago   (1556+ words) How agentic artificial intelligence is transforming the value chain from discovery to commercialization. The biopharmaceutical industry is undergoing a profound transformation, driven by the emergence of agentic artificial intelligence (AI). Unlike traditional AI models that require continuous human guidance, agentic…...

3+ day, 12+ hour ago   (124+ words) Pharmaceutical Executive Sponsored by Paysign Bryan Dennison, Senior Vice President of Sales and Product at Paysign, explains the technical foundation of ClaimGuardRx, a proprietary large language model (LLM) trained specifically on patient affordability claim patterns rather than adapted from a general-purpose…...

3+ day, 15+ hour ago   (40+ words) Unlocking the Future of Real-World Data & Research Pharmaceutical Executive Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B Trusted Research Environments Are Reshaping Real-World Data Access: Q&A with Mark Cziraky FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults...

5+ day, 15+ hour ago   (497+ words) Pharmaceutical Executive The pharma and biotech industries run on data, especially on the R&D side Data is one of the most valuable assets, but it can also cause some of the biggest headaches Due to the wide array of…...

1+ week, 4+ day ago   (78+ words) Pharmaceutical Executive RBQM implementations fail not because the software is wrong — but because the human environment surrounding it was never engineered. There is a myth in our industry that when an RBQM implementation fails to deliver the cause must be…...

1+ week, 4+ day ago   (400+ words) ACTO’s CEO on AI trust, the future of the sales rep, and why human intelligence plus empathetic agents is the winning formula. Over recent years, the pharmaceutical industry has generally embraced AI. Due the nature of the technology, various companies…...

1+ week, 4+ day ago   (247+ words) Carelon Research's Mark Cziraky on why the industry's need for deeper, linked data is driving a shift toward trusted research environments. The pharma and biotech industries run on data, especially on the R&D side. Data is one of the…...

2+ week, 3+ day ago   (57+ words) Why Global Science Innovation is Shifting to Asia Pharmaceutical Executive Pharmaceutical Executive Daily: FDA Approves Imaavy for wAIHA What Executives and Investors Are Looking for in Pharma Companies FDA Approves Imaavy for Warm Autoimmune Hemolytic Anemia in Patients Aged 12 and…...

2+ week, 3+ day ago   (118+ words) Pharmaceutical Executive Why traditional power calculations leave asset value on the table, and how adaptive frameworks change the math on risk. Most Phase 2 trials are sized on a guess seen as mathematics. You are in the trial design meeting, your…...